These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8055336)
1. Vasopressin V1 receptor in rat hippocampus is regulated by adrenocortical functions. Saito R; Ishiharada N; Ban Y; Honda K; Takano Y; Kamiya H Brain Res; 1994 May; 646(1):170-4. PubMed ID: 8055336 [TBL] [Abstract][Full Text] [Related]
2. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats. Antoni FA; Holmes MC; Kiss JZ Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722 [TBL] [Abstract][Full Text] [Related]
3. Corticosteroid regulation of gene expression and binding characteristics of vasopressin receptors in the rat brain. Patchev VK; Almeida OF Eur J Neurosci; 1995 Jul; 7(7):1579-83. PubMed ID: 7551184 [TBL] [Abstract][Full Text] [Related]
4. Effects of an orally active vasopressin V1 receptor antagonist. Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950 [TBL] [Abstract][Full Text] [Related]
5. Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells. Jamil KM; Watanabe T; Nakao A; Okuda T; Kurokawa K Biochem Biophys Res Commun; 1993 Jun; 193(2):738-43. PubMed ID: 8390252 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat. Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI J Endocrinol; 1993 Aug; 138(2):259-66. PubMed ID: 8228734 [TBL] [Abstract][Full Text] [Related]
7. Arginin-vasopressin regulates proliferative activity of the regenerating rat adrenal cortex. Trejter M; Carraro G; Rucinski M; Hochol A; Rebuffat P; Nussdorfer GG; Malendowicz LK Int J Mol Med; 2005 Jun; 15(6):993-7. PubMed ID: 15870905 [TBL] [Abstract][Full Text] [Related]
8. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors. Yamauchi T; Ogura T; Oishi T; Harada K; Hashimoto M; Mimura Y; Asano N; Ota Z; Kageyama J Acta Med Okayama; 1995 Feb; 49(1):53-9. PubMed ID: 7762410 [TBL] [Abstract][Full Text] [Related]
9. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations. Furukawa Y; Takayama S; Ren LM; Sawaki S; Inoue Y; Chiba S J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408 [TBL] [Abstract][Full Text] [Related]
10. Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells. Okada K; Ishikawa S; Saito T Biochem Biophys Res Commun; 1991 Jul; 178(2):707-12. PubMed ID: 1650196 [TBL] [Abstract][Full Text] [Related]
11. Vasopressin potentiates mineralocorticoid selectivity by stimulating 11 beta hydroxysteroid deshydrogenase in rat collecting duct. Alfaidy N; Blot-Chabaud M; Bonvalet JP; Farman N J Clin Invest; 1997 Nov; 100(10):2437-42. PubMed ID: 9366557 [TBL] [Abstract][Full Text] [Related]
12. Arginine vasopressin-induced natriuresis in the anaesthetized rat: involvement of V1 and V2 receptors. Smith CP; Balment RJ J Endocrinol; 1993 Feb; 136(2):283-8. PubMed ID: 8459193 [TBL] [Abstract][Full Text] [Related]
13. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist. Yamamura Y; Ogawa H; Chihara T; Kondo K; Onogawa T; Nakamura S; Mori T; Tominaga M; Yabuuchi Y Science; 1991 Apr; 252(5005):572-4. PubMed ID: 1850553 [TBL] [Abstract][Full Text] [Related]
14. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor. Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327 [TBL] [Abstract][Full Text] [Related]
15. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats. Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678 [TBL] [Abstract][Full Text] [Related]
16. Evidence for the existence of vasopressin V2 receptor mRNA in rat hippocampus. Hirasawa A; Nakayama Y; Ishiharada N; Honda K; Saito R; Tsujimoto G; Takano Y; Kamiya H Biochem Biophys Res Commun; 1994 Dec; 205(3):1702-6. PubMed ID: 7811254 [TBL] [Abstract][Full Text] [Related]
17. In vitro macro- and microautoradiographic localization of V1 and V2 receptors in the rat kidney using OPC-21268 and OPC-31260. Mimura Y; Ogura T; Hayakawa N; Otsuka F; Hashimoto M; Yamauchi T; Makino H; Ogawa N Nephron; 1997; 76(3):331-6. PubMed ID: 9226235 [TBL] [Abstract][Full Text] [Related]
18. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs. Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468 [TBL] [Abstract][Full Text] [Related]
19. Regulation of adrenocortical function by vasopressin. Gallo-Payet N; Guillon G Horm Metab Res; 1998; 30(6-7):360-7. PubMed ID: 9694564 [TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo studies of the effects of arginine-vasopressin on the secretion and growth of rat adrenal cortex. Mazzochi G; Malendowicz LK; Meneghelli V; Gottardo G; Nussdorfer GG Histol Histopathol; 1995 Apr; 10(2):359-70. PubMed ID: 7599433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]